Cases of MIS-C spiked during the pandemic, but saw a steep decline thereafter, which experts believe was likely due to vaccination boosting immunity and possibly newer variants causing less severe infections.
But cases are increasing again. The CDC’s Dec. 14 alert emphasizes that low vaccination rates could be one cause and encourages physicians to administer influenza, COVID-19, and RSV immunizations now to patients who are eligible to receive the shots.
Since September, the CDC notes it has “received 30 reports of MIS-C, a rare complication that typically occurs 1 month after SARS-CoV-2 infection, with illness onset among cases occurring from August 6 to November 9, 2023, a relative increase compared with previous months.”
Vaccination rates for the latest COVID-19 shot remains low across the U.S. at 17.2% in adults and 7.7% in children 6 months to 17 years old.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
